Skip to main content

The Wistar Institute

|

2023 Champion Run for Research Takes to the Streets to Support Wistar Trainees

A group of more than 35 Wistar trainees, researchers, staff, and family members donned their sneakers, stretched their hamstrings, and took to the sidewalks of University City on November 13 to participate in the annual Wistar Run for Research. Wist…
Read more
|

How Does our Immune System Respond to Vaccines? 

A Q&A with Wistar’s Dr. Amelia Escolano What got you interested in immunology? My interest in immunology started in college. I took several immunology courses, and I was particularly attracted by antibody biology. One of these cou…
Read more
|

From Lab to Laptop: The Interdisciplinary World of Computational Biology 

Wistar’s Dr. Avi Srivastava seamlessly integrates elements of computer science and traditional biology into his new computational biology research lab. By combining wet and dry lab approaches — experimental biology and computational data — he can be…
Read more
|

Wistar Scientists Engineer New NK cell Engaging Immunotherapy Approaches to Target and potentially Treat recalcitrant Ovarian Cancer

PHILADELPHIA—(Nov. 1, 2023)— The Wistar Institute’s David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center (VIC) and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research, and collaborat…
Read more
|

Jesper Pallesen, MBA, Ph.D.

Assistant Professor, Vaccine & Immunotherapy Center
Read more
|

Notes from the Field: Dr. Ian Tietjen in Africa, Part 5

Dr. Ian Tietjen is a Research Assistant Professor in Wistar’s Montaner Lab, where he investigates traditional African medicinal compounds’ potential for drug origination against viruses like HIV. Dr. Tietjen travels to Africa to work with traditiona…
Read more
|

Dean Stoios Joins The Wistar Institute as Chief Financial Officer

PHILADELPHIA (October 17, 2023) – The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious diseases, announces the appointment of Dean Stoios as Chief Financial Officer. “We are thrilled to welcome Dean to Wi…
Read more
|

Notes from the Field: Dr. Ian Tietjen in Africa, Part 4

Dr. Ian Tietjen is a Research Assistant Professor in Wistar’s Montaner Lab, where he investigates traditional African medicinal compounds’ potential for drug origination against viruses like HIV. Dr. Tietjen travels to Africa to work with traditiona…
Read more
|

Wistar Institute HIV Researcher Wins Two Grants to Explore Using CAR T Cells as HIV Therapy

Dr. Daniel Claiborne of The Wistar Institute was recently awarded two grants to support studying an approach to optimize CAR T cells, a type of engineered cell, for use against HIV. Claiborne, a Caspar Wistar Fellow in Wistar’s Vaccine & Immunot…
Read more
|

Wistar Trainees Celebrate Postdoc Appreciation Week with Trivia Showdown

See if you can beat the winning team at the end of the article! The air is electric with excitement and trepidation. Ph.D. students, research assistants, and postdoctoral fellows alike have gathered in The Wistar’s Grossman Auditorium for one of the…
Read more